Related content

Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis

By          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-01 ,pp. : 1034-1040

Spandidos Publications

Access to resources Recommend Favorite

Percutaneous coronary intervention strategies and prognosis for graft lesions following coronary artery bypass grafting

By              

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1656-1664

Spandidos Publications

Access to resources Recommend Favorite

Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction

By              

Experimental and Therapeutic Medicine, Vol. 5, Iss. 4, 2013-01 ,pp. : 1206-1210

Spandidos Publications

Access to resources Recommend Favorite

Urinary interleukin18 as an early indicator to predict contrastinduced nephropathy in patients undergoing percutaneous coronary intervention

By                

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1263-1266

Spandidos Publications

Access to resources Recommend Favorite

Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-01 ,pp. : 863-867

Spandidos Publications

Access to resources Recommend Favorite